496 related articles for article (PubMed ID: 24754519)
21. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging.
Zottis AD; Beltrame JM; Lara LR; Costa TG; Feldhaus MJ; Pedrosa RC; Ourique F; de Campos CE; Isoppo Ede A; da Silva Miranda F; Szpoganicz B
Chem Commun (Camb); 2015 Jun; 51(56):11194-7. PubMed ID: 26073290
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in magnetoliposome for heart drug delivery.
Namdari M; Cheraghi M; Negahdari B; Eatemadi A; Daraee H
Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-7. PubMed ID: 28272903
[TBL] [Abstract][Full Text] [Related]
23. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
[TBL] [Abstract][Full Text] [Related]
24. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
Ahmed N; Ahmad NM; Fessi H; Elaissari A
Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
[TBL] [Abstract][Full Text] [Related]
25. Toxicity of L-DOPA coated iron oxide nanoparticles in intraperitoneal delivery setting - preliminary preclinical study.
Comănescu MV; Mocanu MA; Anghelache L; Marinescu B; Dumitrache F; Bădoi AD; Manda G
Rom J Morphol Embryol; 2015; 56(2 Suppl):691-6. PubMed ID: 26429160
[TBL] [Abstract][Full Text] [Related]
26. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T
Shen Z; Chen T; Ma X; Ren W; Zhou Z; Zhu G; Zhang A; Liu Y; Song J; Li Z; Ruan H; Fan W; Lin L; Munasinghe J; Chen X; Wu A
ACS Nano; 2017 Nov; 11(11):10992-11004. PubMed ID: 29039917
[TBL] [Abstract][Full Text] [Related]
28. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
[TBL] [Abstract][Full Text] [Related]
29. Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging.
Li Z; Wang SX; Sun Q; Zhao HL; Lei H; Lan MB; Cheng ZX; Wang XL; Dou SX; Max Lu GQ
Adv Healthc Mater; 2013 Jul; 2(7):958-64. PubMed ID: 23322490
[No Abstract] [Full Text] [Related]
30. Superparamagnetic nanoparticles for biomedical applications.
Xiao Y; Du J
J Mater Chem B; 2020 Jan; 8(3):354-367. PubMed ID: 31868197
[TBL] [Abstract][Full Text] [Related]
31. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
[TBL] [Abstract][Full Text] [Related]
32. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
[TBL] [Abstract][Full Text] [Related]
33. Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents.
Bouziotis P; Psimadas D; Tsotakos T; Stamopoulos D; Tsoukalas C
Curr Top Med Chem; 2012; 12(23):2694-702. PubMed ID: 23339765
[TBL] [Abstract][Full Text] [Related]
34. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
Shin J; Anisur RM; Ko MK; Im GH; Lee JH; Lee IS
Angew Chem Int Ed Engl; 2009; 48(2):321-4. PubMed ID: 19040234
[No Abstract] [Full Text] [Related]
35. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
[TBL] [Abstract][Full Text] [Related]
36. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
37. Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.
Chen N; Shao C; Qu Y; Li S; Gu W; Zheng T; Ye L; Yu C
ACS Appl Mater Interfaces; 2014 Nov; 6(22):19850-7. PubMed ID: 25335117
[TBL] [Abstract][Full Text] [Related]
38. Shape Anisotropic Iron Oxide-Based Magnetic Nanoparticles: Synthesis and Biomedical Applications.
Andrade RGD; Veloso SRS; Castanheira EMS
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32244817
[TBL] [Abstract][Full Text] [Related]
39. Contrast agents: magnetic resonance.
Burtea C; Laurent S; Vander Elst L; Muller RN
Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
[TBL] [Abstract][Full Text] [Related]
40. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
Hu Y; Mignani S; Majoral JP; Shen M; Shi X
Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]